A federal appeals court panel lobbed pointed questions Tuesday at lawyers for drugmakers and the state of Louisiana in an effort to determine whether the state’s contract pharmacy law is preempted by federal law.
The over one-hour discussion at the US Court of Appeals for the Fifth Circuit heard arguments from lawyers representing the Louisiana Department of Justice and attorneys from pharmaceutical giants
The drugmakers and trade group each filed an appeal arguing that Louisiana’s Act 358, which prevents drug companies from denying or restricting the delivery of ...